These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38426619)
1. Expression of PTGS2 along with genes regulating VEGF signalling pathway and association with high-risk factors in locally advanced oral squamous cell carcinoma. Kamal MV; Damerla RR; Parida P; Rao M; Belle VS; Dikhit PS; Palod A; Gireesh R; Kumar NA Cancer Med; 2024 Feb; 13(3):e6986. PubMed ID: 38426619 [TBL] [Abstract][Full Text] [Related]
2. Prostaglandin-endoperoxide synthase 2 (PTGS2) gene expression and its association with genes regulating the VEGF signaling pathway in head and neck squamous cell carcinoma. Kamal MV; Damerla RR; Dikhit PS; Kumar NA J Oral Biol Craniofac Res; 2023; 13(5):567-574. PubMed ID: 37559688 [TBL] [Abstract][Full Text] [Related]
3. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis. Tang Y; Xiao Y; Liao R Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899 [TBL] [Abstract][Full Text] [Related]
4. Inverse correlation of CD3 & vascular endothelial growth factor in incisional oral squamous cell carcinoma biopsies predicts nodal metastasis & poor survival of patients. Khan W; Augustine D; Rao RS Indian J Med Res; 2023 May; 157(5):438-446. PubMed ID: 37322630 [TBL] [Abstract][Full Text] [Related]
5. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas. Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317 [TBL] [Abstract][Full Text] [Related]
6. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation. Sappayatosok K; Maneerat Y; Swasdison S; Viriyavejakul P; Dhanuthai K; Zwang J; Chaisri U Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E319-24. PubMed ID: 19300368 [TBL] [Abstract][Full Text] [Related]
7. Vascular Endothelial Growth Factor A (VEGF-A) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Potential Biomarkers for Oral Squamous Cell Carcinoma: A Sri Lankan Study. Edirisinghe ST; Weerasekera M; De Silva DK; Devmini MT; Pathmaperuma S; Wijesinghe GK; Nisansala T; Maddumage A; Huzaini H; Rich AM; De Silva H; Trudy M; Goonasinghe R; De Silva K; Yasawardena S Asian Pac J Cancer Prev; 2023 Jan; 24(1):267-274. PubMed ID: 36708576 [TBL] [Abstract][Full Text] [Related]
8. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. Shang ZJ; Li JR J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226 [TBL] [Abstract][Full Text] [Related]
9. Artemisinin suppressed tumour growth and induced vascular normalisation in oral squamous cell carcinoma via inhibition of macrophage migration inhibitory factor. Yu XH; Wu JB; Fan HY; Dai L; Xian HC; Chen BJ; Liao P; Huang MC; Pang X; Zhang M; Liang XH; Tang YL Oral Dis; 2024 Mar; 30(2):363-375. PubMed ID: 36321394 [TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment. Guo ZC; Jing SL; Jumatai S; Gong ZC Cancer Immunol Immunother; 2023 Jun; 72(6):1523-1539. PubMed ID: 36513851 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA XIST promotes the malignant features of oral squamous cell carcinoma (OSCC) cells through regulating miR-133a-5p/VEGFB. Wu K; Wu W; Wu M; Liu W Histol Histopathol; 2023 Jan; 38(1):113-126. PubMed ID: 35912960 [TBL] [Abstract][Full Text] [Related]
12. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses. Guo H; Li C; Su X; Huang X Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843 [No Abstract] [Full Text] [Related]
13. Notch Signalling: A Potential Therapeutic Pathway in Oral Squamous Cell Carcinoma. Pandey A; Bhuvanadas S; Joseph JP; Jayaraj R; Devi A Endocr Metab Immune Disord Drug Targets; 2021; 21(12):2159-2168. PubMed ID: 33882814 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer. Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310 [TBL] [Abstract][Full Text] [Related]
15. Suprabasin enhances the invasion, migration, and angiogenic ability of oral squamous cell carcinoma cells under hypoxic conditions. Houri A; Mukudai Y; Abe Y; Watanabe M; Nara M; Miyamoto S; Kurihara M; Shimane T; Shirota T Oncol Rep; 2023 May; 49(5):. PubMed ID: 36896786 [TBL] [Abstract][Full Text] [Related]
16. miR-450b promotes cell migration and invasion by inhibiting SERPINB2 in oral squamous cell carcinoma. Wang X; Nie X; Xu G; Gao J; Wang B; Yang J; Song G Oral Dis; 2024 Mar; 30(2):376-389. PubMed ID: 36251494 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of CK19 and VEGF gene expression, ki67 antigen, p53 protein, C-erb-B2, and their relationship in oral squamous cell carcinoma. Shen Y; Xu Z; Liu M; Piao S; Li J Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):233-239. PubMed ID: 35818248 [TBL] [Abstract][Full Text] [Related]
18. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study. Sales CB; Buim ME; de Souza RO; de Faro Valverde L; Mathias Machado MC; Reis MG; Soares FA; Ramos EA; Gurgel Rocha CA J Oral Pathol Med; 2016 Aug; 45(7):481-5. PubMed ID: 26861159 [TBL] [Abstract][Full Text] [Related]
19. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma. Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761 [TBL] [Abstract][Full Text] [Related]
20. Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas. Giatromanolaki A; Koukourakis MI; Sivridis E; Thorpe PE; Brekken RA; Konstantinos S; Fountzilas G; Gatter KC; Harris AL Clin Exp Metastasis; 2000; 18(4):313-9. PubMed ID: 11448062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]